218 related articles for article (PubMed ID: 35854001)
21. HCV affects K
Niu B; Ma L; Yao L; Zhang Y; Su H
Endocrine; 2024 May; 84(2):427-440. PubMed ID: 37962815
[TBL] [Abstract][Full Text] [Related]
22. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
23. N-Glycosylation modulates the membrane sub-domain distribution and activity of glucose transporter 2 in pancreatic beta cells.
Ohtsubo K; Takamatsu S; Gao C; Korekane H; Kurosawa TM; Taniguchi N
Biochem Biophys Res Commun; 2013 May; 434(2):346-51. PubMed ID: 23548572
[TBL] [Abstract][Full Text] [Related]
24. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
[TBL] [Abstract][Full Text] [Related]
25. An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.
Sato Y; Isaji T; Tajiri M; Yoshida-Yamamoto S; Yoshinaka T; Somehara T; Fukuda T; Wada Y; Gu J
J Biol Chem; 2009 May; 284(18):11873-81. PubMed ID: 19276077
[TBL] [Abstract][Full Text] [Related]
26. The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function.
Kurimoto A; Kitazume S; Kizuka Y; Nakajima K; Oka R; Fujinawa R; Korekane H; Yamaguchi Y; Wada Y; Taniguchi N
J Biol Chem; 2014 Apr; 289(17):11704-11714. PubMed ID: 24619415
[TBL] [Abstract][Full Text] [Related]
27. Shedding of N-acetylglucosaminyltransferase-V is regulated by maturity of cellular N-glycan.
Hirata T; Takata M; Tokoro Y; Nakano M; Kizuka Y
Commun Biol; 2022 Aug; 5(1):743. PubMed ID: 35915223
[TBL] [Abstract][Full Text] [Related]
28. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion.
Isaji T; Kariya Y; Xu Q; Fukuda T; Taniguchi N; Gu J
Methods Enzymol; 2010; 480():445-59. PubMed ID: 20816221
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of N-glycan units for assessment of substrate structural requirements of N-acetylglucosaminyltransferase III.
Hanashima S; Korekane H; Taniguchi N; Yamaguchi Y
Bioorg Med Chem Lett; 2014 Sep; 24(18):4533-4537. PubMed ID: 25139566
[TBL] [Abstract][Full Text] [Related]
30. N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan.
Inamori K; Endo T; Gu J; Matsuo I; Ito Y; Fujii S; Iwasaki H; Narimatsu H; Miyoshi E; Honke K; Taniguchi N
J Biol Chem; 2004 Jan; 279(4):2337-40. PubMed ID: 14617637
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
32. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.
Li W; Takahashi M; Shibukawa Y; Yokoe S; Gu J; Miyoshi E; Honke K; Ikeda Y; Taniguchi N
Glycobiology; 2007 Jun; 17(6):655-62. PubMed ID: 17324955
[TBL] [Abstract][Full Text] [Related]
33. Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.
Pocheć E; Rydlewska M; Przybyło M; Lityńska A
Acta Biochim Pol; 2015; 62(2):323-8. PubMed ID: 26098720
[TBL] [Abstract][Full Text] [Related]
34. Alteration in N -acetylglucosaminyltransferase activities and glycan structure in tissue and bile glycoproteins from extrahepatic bile duct carcinoma.
Jin XL; Liu HB; Zhang Y; Wang BS; Chen HL
Glycoconj J; 2004; 20(6):399-406. PubMed ID: 15238704
[TBL] [Abstract][Full Text] [Related]
35. Substrate Preference and Interplay of Fucosyltransferase 8 and N-Acetylglucosaminyltransferases.
Tseng TH; Lin TW; Chen CY; Chen CH; Lin JL; Hsu TL; Wong CH
J Am Chem Soc; 2017 Jul; 139(28):9431-9434. PubMed ID: 28678517
[TBL] [Abstract][Full Text] [Related]
36. Bisecting GlcNAc Is a General Suppressor of Terminal Modification of
Nakano M; Mishra SK; Tokoro Y; Sato K; Nakajima K; Yamaguchi Y; Taniguchi N; Kizuka Y
Mol Cell Proteomics; 2019 Oct; 18(10):2044-2057. PubMed ID: 31375533
[TBL] [Abstract][Full Text] [Related]
37. β1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLCγ-PKC pathways.
Gao Y; Yang F; Su Z; He Z; Xiao J; Xu Y; Zha X; Xu F; Wang L
Biochem Biophys Res Commun; 2018 Oct; 505(2):569-577. PubMed ID: 30274773
[TBL] [Abstract][Full Text] [Related]
38. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
[TBL] [Abstract][Full Text] [Related]
39. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
de-Souza-Ferreira M; Ferreira ÉE; de-Freitas-Junior JCM
Cell Oncol (Dordr); 2023 Jun; 46(3):481-501. PubMed ID: 36689079
[TBL] [Abstract][Full Text] [Related]
40. N-acetylglucosaminyltransferase V negatively regulates integrin α5β1-mediated monocyte adhesion and transmigration through vascular endothelium.
Yang HM; Yu C; Yang Z
Int J Oncol; 2012 Aug; 41(2):589-98. PubMed ID: 22614033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
